Conditions for EM ex-China looking up
– Conditions for emerging markets (EM) ex-China look better for the next few years than they have in recent years.
– Using IMF forecasts from April’s World Economic Outlook database, EM ex-China should grow at 3.7%pa from 2020-23, 2.3% faster than the developed world.
It has long been generally thought to be the case that two of the key drivers of the relative performance of EM equities versus developed world equities are the growth differential between emerging economies and developed economies, and the strength of the US dollar against other global currencies. These relationships can be made more meaningful by excluding China from the EM component of this model (for complicated reasons to do with China’s closed capital account, and more simple reasons to do with the quality of China’s GDP growth statistics).
Supporting this, JP Morgan has published research showing a fairly strong regression relationship between EM vs. DM growth differentials, the move in USD/EUR and capital flows to emerging markets (ex-China). Its research concludes: ‘robustness tests run with a diverse set of external and domestic variables regularly show EM-DM growth differentials and US dollar performance to be dominant drivers of capital flows.’
With this in hand, how do prospects stack up for the rest of 2019 and into 2020?
Growth differential: EM vs DM
The good news is that conditions for EM ex-China look better for the next few years than they have in recent years. During the ‘golden years’ of 2002-12, when the MSCI Emerging Markets index substantially outperformed the MSCI World index, EM ex-China (GDP-weighted) had average GDP growth of 4.6%pa, 3.2% faster than the developed world (source: IMF, for all GDP data here). The difficult period for EM in relative performance terms was 2013-2018, when the EM ex-China relative GDP growth gap was only 1.2 per cent. Using IMF forecasts from April’s World Economic Outlook database, EM ex-China should grow at 3.7%pa from 2020-23, 2.3 per cent faster than the developed world. This should support EM equity outperformance over the next few years.
Looking into what is driving this, two trends appear. The first is the key role of a few Asian economies in driving EM ex-Chinese GDP growth. India is the largest ex-China EM economy (2019 GDP: US$3 trillion) and is the fastest growing (2020-2024 average GDP growth forecast 7.7%), and the combination of these two means that India is expected to represent 35% of the total growth in EM GDP outside of China. As such, India is a key opportunity for EM equity investors, despite not being among the very largest markets by index weight). Smaller, but also key, are Indonesia (US$1.1 trillion; 5.3%) and Korea (US$1.7 trillion; 2.9%). Other markets are mostly too small (eg the Philippines, Egypt) or too slow growing (eg Russia, South Africa) to make a big contribution. Brazil is perhaps the one that might also make a big contribution, although regular followers will be aware of our concerns regarding the success or otherwise of social security reform there.
It should be noted, also, that the IMF forecast a steady slowing of Chinese GDP growth down to 5.6% in 2023, which will act as a headwind to wider EM growth. While that fits with our shorter-term expectations, any successful stimulus policy in China should lift the EM relative growth gap, improving the outlook for equity investors.
So, a positive growth outlook, but a note of caution is the other half of the global macro environment: the US dollar. While we are not G7 currency experts, one trend in the IMF’s forecasts is that the US has had the largest increase in forecast 2020-23 GDP growth of any of the developed markets, which might point to renewed US dollar strength in the future. That would then put focus on inflation, current account balances and other macro-drivers of individual EM equity markets, which is why our process also looks not just at growth, but also the sustainability of that growth.
This article has been prepared by Pendal Fund Services Limited (PFSL) ABN 13 161 249 332, AFSL No 431426 and the information contained within is current as at May 22, 2019. It is not to be published, or otherwise made available to any person other than the party to whom it is provided.
PFSL is the responsible entity and issuer of units in the Pendal Global Emerging Markets Opportunities Fund (Fund) ARSN: 159 605 811. A product disclosure statement (PDS) is available for the Fund and can be obtained by calling 1800 813 886 or visiting www.pendalgroup.com. You should obtain and consider the PDS before deciding whether to acquire, continue to hold or dispose of units in the Fund. An investment in the Fund is subject to investment risk, including possible delays in repayment of withdrawal proceeds and loss of income and principal invested.
This article is for general information purposes only, should not be considered as a comprehensive statement on any matter and should not be relied upon as such. It has been prepared without taking into account any recipient’s personal objectives, financial situation or needs. Because of this, recipients should, before acting on this information, consider its appropriateness having regard to their individual objectives, financial situation and needs. This information is not to be regarded as a securities recommendation.
The information in this article may contain material provided by third parties, is given in good faith and has been derived from sources believed to be accurate as at its issue date. While such material is published with necessary permission, and while all reasonable care has been taken to ensure that the information in this article is complete and correct, to the maximum extent permitted by law neither PFSL nor any company in the Pendal group accepts any responsibility or liability for the accuracy or completeness of this information.
Any projections contained in this article are predictive and should not be relied upon when making an investment decision or recommendation. While we have used every effort to ensure that the assumptions on which the projections are based are reasonable, the projections may be based on incorrect assumptions or may not take into account known or unknown risks and uncertainties. The actual results may differ materially from these projections.